Introduction
Heart failure, the final common pathway of myocardial dysfunction in most forms of cardiac disease, is one of the leading causes of death in developed countries [1] . The incidence of heart failure has increased by a factor of five in the past three decades [2] . Most advanced pharmacological and surgical treatments fail in some patients, and for the most severe forms of cardiac dysfunction leading to irreversible biventricular end-stage heart failure, cardiac transplantation has emerged as the only effective therapy, affording longevity and quality of life [3] . Implantation of a totally artificial heart is another option, but requires complete removal of the native heart [4] . An alternative technique was introduced by DeBakey and coworkers [5] , who were the first to develop a cardiac assist device (CAD). A CAD operates as a mechanical circulatory support system that assists the native heart without needing its removal [6] . The first application of a CAD was performed in 1963 in a patient with a postoperative cardiogenic shock. After CAD implantation, improvement in the patient's cardiac function developed after 1 week of support and the device could be finally removed [5] . In 1971 [7] , DeBakey reviewed his experience with this technology and outlined the lack of a portable control mechanism and power source as being one of the main barriers to its wider use. This is understandable because the first CAD systems were completely or partially paracorporeal and electrically motor driven. This required a cable (drive line) for the energy supply and for device control that was located in a small trolley pulled by the patient [8] . Since their introduction, CAD systems have undergone a substantial evolution, including the development of intracorporeal implants with percutaneous energy transmission by a small battery connected with the patient's belt [9] .
Circulatory support systems are able to act as a left ventricular assist device (LVAD) supporting the left ventricle, as a right ventricular assist device (RVAD) supporting the right ventricle, or as a biventricular assist device (BVAD) supporting both ventricles [10] . Patients receive mechanical circulatory support by implantation of a CAD system for one of the three following intentions: (a) as a bridge-to-transplant that provides circulatory assistance for the patient awaiting heart transplant; (b) as a bridge-to-recovery that provides circulatory assistance allowing the heart to recover (mostly from postcardiotomy cardiogenic shock or myocarditis); or (c) as a long-term and permanent circulatory assistance, being an alternative to heart transplantation (so-called destination therapy) [11] . The last indication was documented to be a promising alternative to heart transplantation in adults [11, 12] .
Because of the increasing use of CAD systems, radiologists are confronted more and more often with such devices in their daily clinical practice. Therefore, radiologists need to be familiar with the typical imaging features of the various CAD systems on conventional radiography and multislice computed tomography (CT), the two most frequently used radiological techniques for imaging these patients, in order to substantiate their role as cardiovascular specialists [13] .
Types of cardiac assist devices
A CAD usually consists of an inflow cannula containing blood from the ventricle that is assisted by the device. The inflow cannula connects the assisted ventricle to the pump where the blood is powered forward into the outflow cannula. The outflow cannula is a connection between the pumping element of the CAD and the corresponding great vessel of the assisted ventricle. The path of the blood flow can be schematically simplified as follows:
LVAD: left ventricle → inflow cannula → pumping element → outflow cannula → ascending aorta RVAD: right ventricle → inflow cannula → pumping element → outflow cannula → pulmonary trunk Currently, there are a wide variety of CAD systems offered by different vendors (Table 1) . Early CAD systems were extensions of the heart-lung machine, which could drain the blood in a nonpulsatile manner from the heart via peripheral vascular access to oxygenate the blood extracorporeally and return it again to the patient, also called extracorporeal membrane oxygenation (ECMO) [14] . The patient was maintained on mechanical ventilation and was sedated, which limited the use of such systems to resuscitation after either cardiac arrest or profound shock [14] . Recent developments have led to devices with pulsatile blood flow corresponding to the physiology of the native heart, whereas the latest evolved systems again show a nonpulsatile axial or centrifugal flow, delivering continuous blood flow with the advantage of size and weight reduction and smaller energy demands [15] . The currently available CAD systems can be categorised into three generations reflecting the order in which they were developed and the type of pumping mechanism used [16] ( Table 1) .
First-generation pumps Development in the early 1980s led to CAD systems being smaller than early pumps used for ECMO. These pumps could generate pulsatile blood flow through pneumatic or air technology compressing a reservoir of blood drained from the ventricle. The size of these devices restricted their use to patients with an adequate size defined by body surface area to ensure device location [17] . This type of device can provide support to the right ventricle, the left ventricle or to both ventricles. An example is the Berlin Heat Excor (Berlin Heart AG, Berlin, Germany), a paracorporeal and pneumatically accentuated pulsatile blood pump, being one of the first devices designed for the use as a LVAD, RVAD or BVAD (Fig. 1a) . The pneumatic drive line connects the device to an external portable console. The paracorporeal external pneumatic pump driver is portable and allows mobility and ambulant care of the patient.
First-generation pulsatile CAD systems have several disadvantages, such as their large size and complexity (e.g. they contain many moving parts, including valves), which can affect the device's durability [18] . A study has shown that pulsatile flow was not able to maintain the integrity of the pulmonary or systemic circulation as well as the organ function, whereas other experiments have suggested evidence to the contrary [19] . However, these devices are still in broad use in many centres because of their versatility, especially in supporting the right ventricle [8] .
An advance in the field of pulsatile devices was the development of implantable pumps. These devices can be implanted either preperitoneally or intraperitoneally, with the inflow to the pump via the left ventricular apex only, and the outflow graft to the ascending aorta [14] . One of these devices is the HeartMate® I (Thermo Cardiosystems, Inc., Woburn, MA, USA) ( Table 1) .
Second-generation pumps Second-generation CAD systems are axial-flow pumps with continuous blood flow. They are considerably smaller and safer because of only one moving part, which is the rotor generating the blood flow. These systems are expected to have a greater durability than first-generation devices. Experience with these devices, e.g. Micromed-DeBakey LVAD (MicroMed Technology, Inc., Houston, TX), HeartMate II® (Thoratec, Pleasanton, CA) and Berlin Heart INCOR (Berlin Heart AG, Berlin, Germany), is increasing [20, 21] (Table 1) . The Berlin Heart Incor (Berlin Heart AG) (Fig. 3a) weighs 200 g and is one of the latest developments in the field of CAD systems designed to work as an LVAD. Remarkably, the continuous blood flow and relative lack of pulsatility appears to be well tolerated, but longer periods of followup are required to confirm this finding [16] . The Micromed-DeBakey (MicroMed Technology, Inc., Houston, TX) is an implantable axial-flow, nonpulsatile pump with a weight below 100 g (Fig. 4a) . Fig. 1 A 51-year-old male patient who underwent surgery for a Berlin Heart Excor intended to work as a BVAD for bridge-totransplant. a Photograph of the Berlin Heart Excor, ex vivo. The device has two connections for the inflow (green arrow) and outflow (red arrow) cannulae. Additionally, the adapter for the pneumatic drive line (blue arrow) is visible. One Berlin Heart Excor, such as illustrated, supports one ventricle. b The CT depicts the two extracorporeally located Berlin Heart Excor pumps (white arrows) and the inflow (green arrows) and outflow (red arrows) cannulae. Note the pneumatic drive line (blue arrows). The four cannulae positions can be inferred from their radiopaque stabilising wires (black arrows). c Chest radiography in a lateral projection depicting the radiopaque stabilising wires (arrows) entering the thoracic cavity through the upper abdominal wall. d Axial thin-slab maximum intensity projection of the computed tomography data set at the level of the ascending aorta (Ao) and pulmonary trunk (TP) demonstrating intact anastomoses of the outflow cannulae (arrows) connecting the Berlin Heart Excor with the aorta and the pulmonary trunk. Note the additional Gore-Tex graft connecting the innominate vein to the right atrium (arrowhead) in this patient. e Oblique axial thin-slab maximum intensity projection of the computed tomography data set at the level of the left (LA) and right (RA) atrium, demonstrating the intact positions of the inflow cannulae (arrows) connecting the CAD to both atria. f Three-dimensional volume rendered computed tomography image in an anterior view provides an overview regarding the complex postsurgical anatomy of the native heart and illustrates the cannulae with their anastomoses (arrows) and the Gore-Tex graft connecting the innominate vein to the right atrium (arrowhead). g Three-dimensional volume rendered computed tomography image in an anterior view illustrates the course of the in-and outflow cannulae entering the thoracic cavity via the upper abdominal wall
Third-generation pumps One of the most promising inventions in CAD technology was the development of centrifugal pumps. These devices are smaller in size compared with pulsatile CAD systems with simplification of their implantation that extends their application to children and small adults [22, 23] . Centrifugal pumps generate continuous, nonphasic blood flow. The current third-generation pumps are thought to last approximately 5 years and their performance is currently being evaluated in several phase I studies involving the Ventrassist® (Ventracor Ltd., Chatswood, Australia) and HVAD® (HeartWare, Miramar, FL) devices, and more recently the DuraHeart® (Terumo Kabushiki Kaisha [Terumo Corporation] Shibuya-ku, Japan) system [16] (Table 1) .
Patient selection
The selection of the CAD depends on the type of heart failure and on the overall severity of the heart disease representing the most important factors in the outcome of patients with CAD [24] . Similar to heart transplantation, the indication for placement of a CAD is an end-stage heart failure that is refractory to maximum medical drug therapy and without consideration of conventional heart surgery or other catheter techniques (e.g. cardiac valvular disease or arrhythmia). It is important to mention that CAD surgery is only the second choice in the absence of an available donor heart because some patients will qualify for CAD but not for heart transplantation. For example, patients with contraindications for immunosuppression, of age higher than 65 years, severe peripheral vascular disease, and severe pulmonary emphysema are precluded from heart transplantation, but may be candidates for CAD [11] .
Patients
Between 1999 and 2007, 43 patients underwent surgery for a CAD at the Clinic for Cardiovascular Surgery of our hospital. Of these 43 patients, 13 (2 women, 11 men; mean age 46.2±9.9 years, range 18-54 years) with an extra-or intracorporeal CAD underwent conventional radiography and CT at our institute. The 13 patients suffered from endstage acute (n=4) or chronic (n=9) heart failure before surgery (Table 2 ). Preoperative underlying heart disease was cardiomyopathy in 12 patients (4 ischaemic, 5 dilatative, 1 idiopathic, 1 following surgery for congenital transposition of the great arteries in childhood, and 1 restrictive cardiomyopathy due to myocardial amyloidosis). All the patients in this group (n=12) were awaiting a cardiac transplant and received a CAD intended for bridgeto-transplant. One patient underwent surgery for a CAD intended for bridge-to-recovery following heart transplantation. CT is not routinely performed in patients after CAD implantation, but only in those in whom complications are suspected. All these 13 patients underwent a chest CT, 4 of whom had an additional abdominal CT. The reasons for referral to chest CT were suspected pneumonia, device thrombosis or malpositioning, pseudoaneurysm formation at the anastomosis site, embolism, haematoma or dissection (Table 2) .
CT protocol
All CT examinations were performed using multislice spiral CT systems (Table 3) . In five patients a 4-slice CT system was used (Volume Zoom, Siemens Medical Solutions, Forchheim, Germany), in three patients a 16-slice CT system (Sensation 16, Siemens), and in five patients a 64-slice CT system (Sensation 64, Siemens). We acquired unenhanced images as well as imaging in arterial and venous phases after intravenous administration of nonionic, iodinated contrast media (Ultravist 300, 300 mg/ml, Bayer Schering Pharma, Berlin, Germany). The beginning of the arterial phase was controlled by bolus tracking after placing a region of interest (ROI) in the proximal descending aorta. With the 4-slice CT system, image acquisition started after the predefined threshold of 100 Hounsfield units (HU) was reached; with the 16-and 64-slice CT systems the threshold was set to 140 HU. The venous phase was performed 80 s after initiation of contrast medium injection. All images were reconstructed using a soft-medium tissue kernel (B30f) and a hard-sharp bone kernel (B50f). Parameters are detailed in Table 3 .
Imaging findings
For the evaluation of the CAD systems, various postprocessing techniques of the CT data sets were used. These included multiplanar reformations (MPR), maximum intensity projections (MIP) and volume rendering (VR). Postprocessing in our patients was performed on an external workstation (Multimodality Workplace, Siemens) Fig. 2 A 61-year-old male patient who underwent surgery for a Berlin Heart Excor RVAD as a bridge-to-recovery. a The CT depicts the Berlin Heart Excor pump that is located extracorporeally (white arrow), as well as the inflow (green arrow) and outflow cannulae (red arrow). The pneumatic drive line of the CAD is also shown (blue arrow). The radiopaque stabilising wires delineate the in-and outflow cannulae in their course through the upper abdominal wall into the thoracic cavity. Note bilateral pacemaker devices (arrowheads) and electrodes. b Axial computed tomography image demonstrates intact anastomosis (arrow) connecting the outflow cannula to the pulmonary trunk (TP). c Axial computed tomography reconstruction at the level of the right atrium (RA) demonstrates an intact position of the inflow cannula at the right atrium (arrow). d Three-dimensional volume rendered computed tomography image in a left anterior oblique view provides an overview of the heart including the right (RV) and left (LV) ventricle, as well as the outflow cannula (arrow) connected to the pulmonary trunk (TP). e Three-dimensional volume rendered computed tomography image in a left posterior oblique demonstrates the inflow cannula (arrow) connected to the right atrium (RA). The left atrium (RA) and the superior vena cava (SVC) are also shown equipped with postprocessing software (Syngo InSpace4D, Siemens).
Berlin Heart Excor
In the patients with a Berlin Heart Excor, conventional radiography (both chest radiography and CT scanogram) allowed for the delineation of the wire-directed in-and outflow cannulae that were placed depending on the type of assistance (BVAD or RVAD, Figs. 1b, c and 2a). The cannulae exit the upper abdominal wall and are connected to the paracorporeally placed blood pump. The pneumatic drive line could be visualised in all patients. Use of postprocessed images with CT allowed for the accurate depiction of the CAD and the native anatomy of the heart and adjacent soft tissue structures, lung and osseous thoracic cage. In the patient with a Berlin Heart Excor BVAD, the outflow cannula in the pulmonary artery and ascending aorta as well as the inflow cannula in the right and left atrium could be clearly visualised (Fig. 1d, e) . In the patient with a Berlin Heart Excor RVAD, the inflow cannula connected to the right atrium and the outflow cannula connected to the pulmonary artery could be Fig. 3 A 58-year old male patient with a Berlin Heart Incor LVAD as a bridge-to-transplant. a Photograph of a Berlin Heart Incor LVAD, ex vivo, designed for use as an LVAD. The connections for the inflow (green arrow) and the outflow (red arrow) cannulae are depicted; access for the drive line for control and energy supply of the pump is also visible (orange arrow). b Chest radiography in a posteroanterior projection shows the inflow (green arrow) and outflow (red arrow) cannulae as well as the pump (thick black arrow), which is located intrapericardially. The radiopaque inflow cannula to the left ventricle (thin black arrow) and the spring lock of the outflow cannula (double arrow) are also depicted. The drive line for control and energy supply of the pump exits through the left upper abdominal wall (orange arrow). In this patient, the left upper abdominal quadrant was chosen for the drive line exit, as the right upper abdominal quadrant, which is usually used, was occupied by an artificial bowel stoma. Note the small loculated pleural effusion in the horizontal fissure (arrowhead). c Chest radiography in a lateral projection depicts the radiopaque Berlin Heart Incor device located in the pericardial cavity (thick black arrow), the inflow cannula of the left ventricle (green arrow), the energy supply cable (orange arrow) and the spring lock of the outflow cannula (double arrow). Note the mechanical mitral valve prosthesis (arrowhead). d Oblique sagittal computed tomography reconstruction at the level of the ascending aorta (Ao) demonstrates intact anastomoses (thick white arrow) of the outflow cannula connecting the pump to the ascending aorta. Note the spring lock (black arrow) at the outflow cannula and the severe metallic artefacts (thin white arrows) evoked by the Berlin Heart Incor (not shown). e Oblique coronal computed tomography reconstruction at the level of the left ventricular apex demonstrates the Berlin Heart Incor with the connections of the inflow (white arrow) and outflow (black arrow) cannulae. f Oblique axial computed tomography reconstruction at the level of the ascending aorta (Ao) and the left ventricle (LV) demonstrate intact anastomoses of the cannulae connecting the pump to the apex of the heart (black arrow) and the ascending aorta (white arrow). g Threedimensional volume rendered computed tomography image in an anterior view illustrating the course and positions of the in-and outflow cannulae, the Berlin Heart Incor (double arrow) and the native heart with the right (RV) and left (LV) ventricle. The anastomoses are connecting the pump to the apex of the heart (arrowhead) and the ascending aorta (arrow) accurately depicted (Fig. 2b, c) . The course of the in-and outflow cannulae exiting the upper abdominal wall as well as the connection to the pumps were demonstrated by CT using the VR technique (Figs. 1f, g and 2d, e).
Berlin Heart Incor
The intracorporeal position of the Berlin Heart Incor could be demonstrated by conventional radiography (Fig. 3b, c) in two projections as well as the in-and outflow cannulae that were placed in the left ventricle and ascending aorta. CT showed the inflow conduit that was placed in the left ventricular apex, and the outflow conduit that was sutured onto the ascending aorta (Fig. 3d-f) . The implantable pump housing was placed inside the pericardial cavity and the drive line exited the abdominal wall through the right upper quadrant. The connection to the pumps could be depicted by using VR images (Fig. 3g) .
Micromed-DeBakey
Both the device and the cannulae positions of the Micromed-DeBakey LAVD were depicted by conventional radiography (Fig. 4b, c) . In the patients with a MicromedDeBakey LVAD, the inflow cannula was placed in the left ventricular apex and the outflow graft was sutured onto the ascending or descending aorta which can be demonstrated by CT (Fig. 4d-f) . The blood pump was placed in the pericardium with little extension into the abdominal wall, and the drive line exited the skin through the right upper abdominal quadrant.
Analysis of image techniques
MPR of CT data generate images of structures that follow an oblique course to the axial plane. This is particularly useful for the illustration of in-and outflow cannulae of the While VR is the most time-consuming postprocessing technique, it is helpful for the three-dimensional visualisation of complex anatomy (Fig. 3g) . VR in patients with CAD systems usually was performed using the data sets that were reconstructed with a soft-medium tissue reconstruction filter. Use of a hard-sharp bone filter was superior in reducing the metallic artefacts of the Incor devices.
In general, we recommend the combined use of the various postprocessing CT techniques which improves the comprehensive overall understanding of the cardiovascular anatomy and therefore potentially reduces the time needed for a CT-based diagnosis [25] . This holds true, despite the fact that the greatest amount of structural information, like the anastomoses of the in-and outflow cannulae, is usually obtained by MPR alone [26] .
In our patients, CT provided a very good and detailed visualisation of the CAD systems including the position and anastomosis sites of the in-and outflow cannulae, which corroborates the results of a previous study [27] . Similar to the work of Knollmann et al. [28] , CT was superior in the evaluation of anastomoses for all devices compared with conventional radiography. The latter depicts the in-and outflow cannulae and positioning of the blood pump itself, but lacks detailed morphologic information regarding the heart and CAD. On the other hand, intracorporeally located CAD systems resulted in considerable metallic artefacts, which limit the diagnostic quality, especially in the region surrounding the devices [29] .
CT protocol
The CT protocol was chosen according to the respective indication. If haemorrhage was suspected, we used a threephase CT protocol, including an unenhanced image to allow measurement of CT attenuation in potential fluid collections. The same protocol was used when pseudoaneurysm formation at the anastomosis site or thrombosis of the device was suspected. We suggest that unenhanced images are used for visualising the metallic parts of the CAD systems and to differentiate potential vessel calcifications from contrast-enhanced structures. The arterial phase of contrast enhancement was very helpful for the depiction of the in-and outflow cannulae of the CAD systems and the great vessels of the heart. The venous phase of contrast enhancement was added for evaluation of the anastomoses of the in-and outflow cannulae with regard to possible pseudoaneurysms or contrast media extravasation. We advise a single venous phase of contrast enhancement in those patients for whom the aim was to rule out a focus of infection. When pneumonia was suspected, only unenhanced CT was performed. From our experience, the use of a flexible CT imaging protocol adjusted to the individual clinical indication appears more adequate than using a fixed three-phase protocol, particularly for avoiding Fig. 5 A 56-year-old male patient who underwent surgery for an intracorporeally placed Micromed-DeBakey LVAD as a bridge-totransplant. Axial computed tomography reconstruction at the level of the pulmonary trunk (TP) demonstrates a mediastinal haematoma (white arrow) surrounding the intact anastomosis of the outflow cannula, connecting the device to the ascending aorta (black arrow) Fig. 6 A 47-year-old male patient who underwent surgery for an intracorporeally placed Berlin Heart Incor as a bridge-to-transplant. Axial computed tomography reconstruction at the level of the left (LA) and right (RA) atrium demonstrates an infected fluid collection in the anterior mediastinum with peripheral contrast enhancement (white thin arrows). Note the correct positioning of the inflow cannula (black arrow) in the left ventricle (LV), the outflow graft in its course to the ascending aorta (thick white arrow), and pacemaker electrodes in the RA and right ventricle unnecessary radiation exposure. Electrocardiography (ECG) gating was not used in any patient because evaluation of the coronary arteries was not the focus of these CT examinations. Nevertheless, when imaging of coronary arteries or of potential coronary artery bypass grafts is required, the CT data acquisition should be synchronised to the ECG. The electrical conduction system of the native heart is in good order in most of the patients and works independently from the assist device [29] . Furthermore, the use of ECG synchronisation in patients with a CAD may improve the image quality by reducing motion artefacts [29] .
Complications
The incidence of complications associated with the implantation of CAD is approximately 67% and includes haemorrhage, heart failure, renal dysfunction, infection, neurological events, thromboembolic events, as well as thrombosis and air embolism [30, 31] . Device failure can be life-threatening and requires device exchange. In the REMATCH study [32] , 17% of deaths were caused by device failure. The mortality in patients requiring BVAD as a bridge-to-transplant has been reported to be more than 40% in contrast to the 25% mortality of patients bridged on LVAD [33] . Generally, conventional radiography and CT are both useful techniques that may aid in the detection of complications [11, 34] , whereas CT is superior in characterisation of these complications such as haemorrhage and infections.
Haemorrhage
Haemorrhage occurs either as an early event following surgery or later due to a connection insufficiency. Haemorrhage may appear as abnormal circumferential density surrounding a device and/or its cannulae (Fig. 5) . There is evidence that the inner surface of LVAD contributes to the bleeding tendency of the activating platelets, along with evidence that LVAD themselves initiate the activation of the fibrinolytic pathway [34] . Mechanisms that alter the tendency to bleed are routine anticoagulation, platelet inhibition, hepatic dysfunction and a poor nutritional status [34] . However, with the Berlin Heart Excor, it is possible to fully reverse anticoagulation after implantation that may result in a low incidence of haemorrhage which has been one of the major surgical obstacles in the early experience with CAD [35] .
Infections
Infectious complications, which are largely caused by the presence of the drive line across the skin barrier, have been reported to occur in almost half of the LVAD recipients [36] . Such complications may occur anywhere along the device itself and all its conduits and connecting cannulae and grafts due to fibrin deposits triggering activity of infecting organisms. Infection may appear as a loculated fluid collection adjacent to a device part (Fig. 6 ).
Thromboembolism
A source of embolism may be the pump itself and its artificial cardiac valves, as well as the native chambers or valves of the heart. Thromboembolism often causes neurologic complications.
Conclusions
Patients with end-stage heart failure may receive mechanical circulatory support by implantation of a CAD intended for bridge-to-transplant, bridge-to-recovery or as a permanent alternative to heart transplantation. CAD therapy is a continuously evolving field with an increasing number of implantations over the last 20 years. The MicromedDeBakey LVAD, the Berlin Heart Incor LVAD and the Berlin Heart Excor are frequently implanted artificial blood pumps. Every CAD has its own footprint that produces a specific radiological appearance on conventional radiography and CT. CT is the modality of choice that comprehensively allows one to delineate the in-and outflow cannulae and positioning of the blood pump itself, as well as potential CAD-associated complications like mediastinal haemorrhage, infection and thromboembolism.
